A Phase 1b/Randomized Phase 2 Study to Evaluate LY3039478 in Combination with Dexamethasone in T-ALL/T-LBL Patients

Trial Profile

A Phase 1b/Randomized Phase 2 Study to Evaluate LY3039478 in Combination with Dexamethasone in T-ALL/T-LBL Patients

Completed
Phase of Trial: Phase I/II

Latest Information Update: 17 Jul 2018

At a glance

  • Drugs Crenigacestat (Primary) ; Dexamethasone (Primary)
  • Indications Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 09 Jul 2018 Status changed from active, no longer recruiting to completed.
    • 19 Apr 2018 This study has been completed in Germany (End date: 2018-01-15).
    • 18 Apr 2018 This study has been completed in Sweden (End date: 2018-01-15).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top